. Effects of AMA and compounds 1-6 on the viability of Neo Jurkat cells (low expression of Bcl-2) and BCL Jurkat cells (overexpression of Bcl-2). The cells were treated with 10 (left bar), 50 (center bar), and 100 M (right bar) concentrations of the test compounds for 24, 48, 72, and 96 h. There was no obvious difference between the effects on cells with low and high expression of Bcl-2, indicating that the inhibition was not Bcl-2 dependent. Values are presented as means ± SD (n = 3). 3S . Fluorescence microscopy images of A549 cells after a 4 h incubation with compounds AMA, 4, and 6 (blue channel) at 50 M concentration and MitoTracker red (red channel) at 100 nM concentration. The red fluorescence (MitoTracker red) was used to observe mitochondria and the blue fluorescence imaging was carried out with a 9 s exposure time to observe the uptake of AMA derivatives. Fig. 4S . Dose-response curves as calculated using Prism's nonlinear regression curve fit analysis model of GraphPad Software (La Jolla, CA, USA) and reported with 95% CI as indicated in parentheses. Fig. 4S (continued) . Dose-response curves as calculated using Prism's nonlinear regression curve fit analysis model of GraphPad Software (La Jolla, CA, USA) and reported with 95% CI as indicated in parentheses. Fig. 4S (continued) . Dose-response curves as calculated using Prism's nonlinear regression curve fit analysis model of GraphPad Software (La Jolla, CA, USA) and reported with 95% CI as indicated in parentheses. Fig. 4S (continued) . Dose-response curves as calculated using Prism's nonlinear regression curve fit analysis model of GraphPad Software (La Jolla, CA, USA) and reported with 95% CI as indicated in parentheses. Fig. 4S (continued) . D Dose-response curves as calculated using Prism's nonlinear regression curve fit analysis model of GraphPad Software (La Jolla, CA, USA) and reported with 95% CI as indicated in parentheses.
